ZIOPHARM Oncology, Inc.Home | Contact Us | Sitemap
About UsClinical DevelopmentPartnershipsPatients/ProvidersInvestorsPress and Media




Investors




| Investors Home | Stock Performance | Financial Reports | Events & Presentations | Corporate Governance | Shareholder Services | Investor Toolkit | Contact Us |

INSIDER OWNERSHIP

Related Links

Print Print page | Email Email page

Name Relationship / Title Current Shares Trading Activity
abercrombie george b Director 25,000 View
bagley richard e Officer 209,125 View
brennan murray Director 67,500 View
cannon james anthony Director 242,500 View
essex woodlands health ventures fund vi l p Beneficial Owner (10% or more) 2,371,642 View
fowler wyche Director 67,500 View
fragin gary s Director 67,500 View
gale robert peter Officer 0 View
lewis jonathan Officer 645,025 View
mcinerney timothy Director 230,705 View
paloma international l p Beneficial Owner (10% or more) 1,214,456 View
rosenwald lindsay a md Beneficial Owner (10% or more) 1,214,455 View
schwartz brian Officer 25,000 View
weiser michael Director 150,945 View

Stock transaction information provided by EDGAR Online. ZIOPHARM Oncology, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Stock Information
ZIOP - (NASDAQ)
$3.88   + 0.07
Sep 8, 2010
4:00 PM ET